Clinical Trials Logo

Solid Organ Malignancies clinical trials

View clinical trials related to Solid Organ Malignancies.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01218555 Completed - Clinical trials for Neuroendocrine Tumors

Study of Everolimus (RAD001) in Combination With Lenalidomide

Start date: September 9, 2010
Phase: Phase 1
Study type: Interventional

The purpose of this study is to study the combination of two anticancer drugs, everolimus (RAD001) and lenalidomide in patients whose cancer is no longer responding to standard treatment or patients who are unable to tolerate the standard treatment for their cancer.